Atopic dermatitis (AD) is the most prevalent dermatological disease in the pediatric population. It is a chronic, pruritic, and inflammatory skin disorder, with a complex etiology involving genetic predisposition, skin barrier defects, and immune dysfunction. AD can be a challenge for patients, physicians, and caregivers and has a clear impact in patients’ quality of life (QoL). Educational programs for patients with AD and their caregivers are effective in improving adherence, QoL, and clinical outcomes. Different models of educational programs exist and their structures depend on cultural, social, and economic factors. To improve existing programs, the educational team should go beyond the disease and have a broader view of the many aspects involved in the pathological process. These include psychological, environmental, social, financial, and cultural aspects. Patients and their caregivers should have a more realistic expectation about the treatment. Innovative methods and approaches like design thinking can create new and effective solutions for patients with AD and their caregivers.
Get full access to this article
View all access options for this article.
References
1.
HanifinJM, CooperKD, HoVC, et al.Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines”. J Am Acad Dermatol, 2004; 50:391–404.
2.
SpielmanSC, LeBovidgeJS, TimmonsKG, SchneiderLC. A review of multidisciplinary interventions in atopic dermatitis. J Clin Med, 2015; 4:1156–1170.
3.
HoareC, Li Wan PoA, WilliamsH. Systematic review of treatments for atopic eczema. Health Technol Assess, 2000; 4:1–191.
4.
KantorR, ThyssenJP, PallerAS, SilverbergJI. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of ‘atopic dermatitis’. Allergy, 2016; 71:1480–1485.
5.
SidburyR, TomWL, BergmanJN, et al.Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol, 2014; 71:1218–1233.
6.
CoghiS, BortolettoMC, SampaioSAP, de AndradeHF, AokiV. Quality of life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clinics, 2007; 62:235–242.
7.
ChamlinSL, CellaD, FriedenIJ, et al.Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol, 2005; 125:1106–1111.
8.
KongTS, HanTY, LeeJH, SonSJ. Correlation between severity of atopic dermatitis and sleep quality in children and adults. Ann Dermatol, 2016; 28:321–326.
9.
ManzoniAP, WeberMB, NagatomiAR, PereiraRL, TownsendRZ, CestariTF. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol, 2013; 88:894–899.
10.
EmanuelEJ, EmanuelLL. Four models of the physician-patient relationship. JAMA, 1992; 267:2221–2226.
11.
TakaokaR, CicchiniT, AokiV. Creating new solutions for the patient with atopic dermatitis. Br J Dermatol, 2014; 170: E41.
12.
CorkMJ, BrittonJ, ButlerL, YoungS, MurphyR, KeohaneSG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol, 2003; 149:582–589.
13.
Blume-PeytaviU, LavenderT, JenerowiczD, et al.Recommendations from a European Roundtable Meeting on best practice healthy infant skin care. Pediatr Dermatol, 2016; 33:311–321.
14.
ErsserSJ, LatterS, SibleyA, SatherleyPA, WelbourneS. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev, 2007: CD004054.
15.
SanterM, BurgessH, YardleyL, et al.Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs, 2013; 69:2493–2501.
16.
WeberMB, Fontes Neto PdeT, PratiC, et al.Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol, 2008; 22:992–997.
ChalmersJR, SchmittJ, ApfelbacherC, et al.Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol, 2014; 171:1318–1325.
19.
BrobergA, KalimoK, LindbladB, SwanbeckG. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol, 1990; 70:495–499.
20.
GielerU, KöhnleinB, SchauerU, FreilingG, StangierU. [Counseling of parents with children with atopic dermatitis]. Hautarzt, 1992; 43Suppl 11:37–42.
21.
WenningerK, KehrtR, von RüdenU, et al.Structured parent education in the management of childhood atopic dermatitis: the Berlin model. Patient Educ Couns, 2000; 40:253–261.
22.
StaabD, von RuedenU, KehrtR, et al.Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol, 2002; 13:84–90.
23.
FutamuraM, MasukoI, HayashiK, OhyaY, ItoK. Effects of a short-term parental education program on childhood atopic dermatitis: a randomized controlled trial. Pediatr Dermatol, 2013; 30:438–443.
24.
ErsserSJ, CowdellF, LatterS, et al.Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev, 2014: CD004054.
25.
BarbarotS, BernierC, DeleuranM, et al.Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol, 2013; 30:199–206.
26.
AhrensB, StaabD. Extended implementation of educational programs for atopic dermatitis in childhood. Pediatr Allergy Immunol, 2015; 26:190–196.
27.
SchmittJ, SpulsP, BoersM, et al.Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy, 2012; 67:1111–1117.
28.
ChalmersJR, SimpsonE, ApfelbacherCJ, et al.Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol, 2016; 175:69–79.
BeebeA, GelfandEW, BenderB. A randomized trial to test the effectiveness of art therapy for children with asthma. J Allergy Clin Immunol, 2010; 126:263–266, 266.e1.
32.
BrownT, WyattJ. Design thinking for social innovation. Stanford Soc Innov Rev, 2010; 8:30–35.
33.
BrownT. Design Thinking. Harv Bus Rev, 2008; 86:84–92.
